Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

Youngji Jo, Lise Jamieson, Ijeoma Edoka, Lawrence Long, Sheetal Silal, Juliet R.C. Pulliam, Harry Moultrie, Ian Sanne, Gesine Meyer-Rath, Brooke E Nichols
doi: https://doi.org/10.1101/2020.09.24.20200196

Article usage

Article usage: September 2020 to November 2024

AbstractFullPdf
Sep 2020588093
Oct 20205870306
Nov 20204570196
Dec 20203570104
Jan 20213430146
Feb 20212100149
Mar 202122411165
Apr 20211598161
May 2021154679
Jun 2021161565
Jul 2021103236
Aug 202179648
Sep 202195234
Oct 202176139
Nov 202181544
Dec 202167021
Jan 202233510
Feb 202241015
Mar 2022433034
Apr 202234416
May 20223649
Jun 202241215
Jul 202232010
Aug 20223457
Sep 202237316
Oct 202234016
Nov 202217211
Dec 20222529
Jan 202335710
Feb 20232349
Mar 20231727
Apr 20232327
May 202312312
Jun 20232687
Jul 20231217
Aug 202329168
Sep 20231854
Oct 20232634
Nov 2023371910
Dec 20231607
Jan 2024704
Feb 20242568
Mar 202415411
Apr 202412108
May 202415112
Jun 202410632
Jul 20248469
Aug 202412352
Sep 202422539
Oct 202414722
Nov 20241429
Back to top
Posted September 27, 2020.
Download PDF
Data/Code
Email
Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
Youngji Jo, Lise Jamieson, Ijeoma Edoka, Lawrence Long, Sheetal Silal, Juliet R.C. Pulliam, Harry Moultrie, Ian Sanne, Gesine Meyer-Rath, Brooke E Nichols
medRxiv 2020.09.24.20200196; doi: https://doi.org/10.1101/2020.09.24.20200196
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area